Maternal Type 1 #Diabetes May Protect Children Through #Epigenetic Changes A study from #HelmholtzMunich, #GPPAD & the TU Dresden University of Technology reveals that specific epigenetic modifications in the child’s DNA may underlie this protective effect. 👉 t1p.de/2emq1 @tudresden.bsky.social

#BNMRZ Symposium 2025 Ultra-Highfield NMR and 4D Structural Biology – From Mechanisms to Therapies 💻 Online attendance is still possible: t1p.de/zdr8j 👉 Further information: t1p.de/rjuz4 @tum.de #StructuralBiology #CryoEM #AI #TherapeuticInnovations

New Switch for Natural Cell Death🧬 Programmed cell death (#apoptosis) protects us, but cancer cells can evade it. Researchers at #HelmholtzMunich & TUM discovered a new molecular switch controlling this process. 👉 t1p.de/3fxvc @tum.de @natureportfolio.nature.com #CellDeath #BNMRZ

Comparing Pancreas Development Across Species to Advance Diabetes Research New insights from international researchers led by #HelmholtzMunich & #DZD could reshape the future of #diabetes modeling & #RegenerativeMedicine. 👉 t1p.de/zg0ra @diabresearch-dzd.bsky.social @heikolickert.bsky.social

New Foundation Model Reveals How Cells Are Organized in Tissues Researchers at #HelmholtzMunich & @tum.de have developed #Nicheformer, the first large-scale foundation model that integrates single-cell analysis with spatial transcriptomics. 👉 t1p.de/pxzwg

PURA Syndrome Deutschland Supports Research at Helmholtz Munich 👉 t1p.de/jdvhp  💙 PURA Syndrome Deutschland e.V. has donated 10,000 Euros to Prof. Dierk Niessing’s research group at the Institute of Structural Biology at #HelmholtzMunich.

Decoding #Oat Diversity for a #Climate-Resilient Future🌾 This study provides valuable insights into how oats adapt to their environments – paving the way for more robust, climate-smart crops. 👉 t1p.de/gmmgb @leibniz-gemeinschaft.de @natureportfolio.nature.com @tum.de

🎖️ Prof. Ulrike Protzer receives the “Bundesverdienstkreuz” (Federal Cross of Merit) in recognition of her outstanding contributions to the field of virology. 👉 Read more in our news: t1p.de/gkjvc @ulrike-protzer.bsky.social @tum.de #Virology #TherVacB #HepatitisB

✨ Prof. Eric Topol visited #HelmholtzMunich for a roundtable on the future of #AI in healthcare. The discussion focused on the concept of the #VirtualHuman. 👉Read more: t1p.de/5wthc #AIinMedicine #DigitalHuman #PrecisionMedicine

Genetic Links Between Type 2 Diabetes and Multiple Health Conditions 🧬 A study led by Prof. Eleftheria Zeggini, Director of the Institute of Translational Genomics at #HelmholtzMunich, investigates how genetic risk for type 2 diabetes can influence a wide range of health conditions. 👉 t1p.de/yq19p

Helmholtz Munich at #ICCV2025 🤖 🌺 Our researchers from @comphealthmunich.bsky.social present cutting-edge #AI & #ComputerVision work in Hawaii. 👉 Explore their papers & more: t1p.de/8jfgn #MachineLearning #ICCV #HelmholtzMunich

Starker Andrang bei der FORSCHA 2025 🚀 #HelmholtzMunich war vertreten & zeigte gemeinsam mit unterschiedlichen Instituten und Einrichtungen ein vielfältiges, interaktives Programm. 👉Mehr dazu: t1p.de/8jfjd @munichimaging.bsky.social

🌟 Prof. Ulrike Protzer (4th from left), Director of the Institute of Virology at #HelmholtzMunich and Chair for Virology at the Technical University of Munich at @tum.de, has been awarded the #GermanMedicalAward2025 in the category “Female Doctor of the Year”. 👉 Read more: t1p.de/es04m

✨ Dr. Janna Nawroth from the Helmholtz Pioneer Campus at #HelmholtzMunich has received the #VolkswagenStiftung Night Science Grant, a program fostering #creativity and bold ideas in research. 👉 Read more: t1p.de/kmm5p @volkswagenstiftung.de @pioneercampus.bsky.social

#Podcast-Tipp: In der aktuellen Folge des BR-Podcasts „IQ – Wissenschaft und Forschung“ sprechen die #HelmholtzMunich Forscherinnen Prof. Magdalena Götz und Prof. Annette Peters über das wissenschaftliche Verständnis von #Longevity. 🎧Jetzt anhören: t1p.de/na4hp @brkommunikation.bsky.social

How Genomes Support Resilient Wheat As part of the 10+ Wheat Genomes Project, researchers from #HelmholtzMunich & Earlham Institute built the first wheat pan-transcriptome, mapping gene activity across varieties. 👉 t1p.de/cxxdv @wheatinitiative.bsky.social

🩸 #Prediabetes: Blood Sugar Level Is More Important Than Body Weight A study finds that normalizing #BloodSugar through lifestyle changes can reduce the risk of #Type2Diabetes, even without weight loss. 👉 t1p.de/tal6o #HelmholtzMunich @unituebingen.bsky.social @diabresearch-dzd.bsky.social

🔬 #Neurodermatitis: How a Skin Bacterium Can Strengthen the Skin Barrier A new study shows how the skin bacterium Staphylococcus hominis can strengthen the skin barrier & reduce inflammation. 👉Read more in our news: t1p.de/mx3bs 📄Original publication: t1p.de/wfpiv @traidlhoffmann.bsky.social

🎊 @zeynepakata.bsky.social wird mit dem den „ZukunftsWissen“-Preis von Leopoldina und Commerzbank-Stiftung ausgezeichnet. Geehrt wird die Informatikerin @tum.de @helmholtzmunich.bsky.social für ihre wissenschaftlichen Leistungen auf dem Gebiet der erklärbaren #KI.

#WorldLungDay "Healthy Lungs, Healthy Life"🫁 At #HelmholtzMunich, researchers are paving the way for therapies of #LungDiseases. 🎥 Watch & learn how to prevent & treat COPD! @onderyildirimcpc.bsky.social #COPD2025 #LungHealth #COPD-iNet

#HelmholtzDiabetes2025 Diabetes and Liver Health in Focus at the 12th Helmholtz Diabetes Conference Leading scientists from around the world gathered to explore the role of #liver health in #diabetes and other metabolic diseases. 👉Read more: t1p.de/u915r @diabresearch-dzd.bsky.social

#HelmholtzDiabetes2025 Philipp Scherer Was Honored With the Helmholtz Diabetes Lecture Award👏 🎥 Watch the video and learn more about his research and thoughts on the conference! @diabresearch-dzd.bsky.social #DiabetesResearch #LiverHealth #MetabolicDisease

#HelmholtzDiabetes2025 This year’s conference highlights the growing impact of fatty #liver disease on #diabetes development. Prof. Anja Zeigerer, co-host and researcher at #HelmholtzMunich & @uniheidelberg.bsky.social, studies how nutrient transport in the liver drives diabetes and obesity.

#HelmholtzDiabetes2025 Mapping Feeding Circuits in the Human Brain 🧠 In the Keynote Lecture at the #HelmholtzDiabetesConference, Prof. Giles Yeo discussed how the #brain regulates appetite & energy balance. 🎥Watch the interview⬇️ @gilesyeo.bsky.social @cam.ac.uk @diabresearch-dzd.bsky.social

🚀 #NAKO Launches the Pilot Phase of Its Trusted Research Environment 📝 Health-focused companies can now apply for secure, GDPR-compliant access to Germany’s largest long-term population health data. 👉 Read more: t1p.de/q0i64 @nako.de #HelmholtzMunich #DataProtection #HealthResearch

#HelmholtzDiabetes2025 The 12th Helmholtz Diabetes Conference has just started! 🚀 🌟Experts in #diabetes, #obesity & metabolic liver disease share their findings. Host: Prof. Stephan Herzig | Co-host: Prof. Anja Zeigerer 🎥 Why liver health matters in #DiabetesResearch! #MetabolicResearch

🎉🎬 @zeynepakata.bsky.social erhält den diesjährigen „ZukunftsWissen“-Preis von Leopoldina & Commerzbank-Stiftung. Die Informatikerin @tum.de und Helmholtz_Munich spricht über ihre Forschung zur erklärbaren #KI. Zum Video auf YouTube: www.youtube.com/watch?v=ZqIH...

🔬 Researchers led by Dr. Siegfried Ussar have identified insulin-like growth factor 2 (IGF2) as a central driver of fat tissue expansion during early postnatal development. 👉 Read more: t1p.de/71yka @diabresearch-dzd.bsky.social @genesdev.bsky.social #DiabetesResearch #IGF2

Oktoberfest Symposium 2025 – Advancing Type 1 Diabetes Research International experts in #type1diabetes are sharing the latest clinical insights & research findings: 👉Register now: t1p.de/mxt4n 📍 Conference Center, Campus #HelmholtzMunich 📅 Sept 30, 2025 @diabresearch-dzd.bsky.social @tum.de

🫁 #HelmholtzMunich and @parse.bsky.social are creating one of the largest #lung disease perturbation atlases. They will study lung cells to see how treatments affect them, guiding future #therapies & #AI models of lung biology. 👉 t1p.de/kj98f @fabiantheis.bsky.social @comphealthmunich.bsky.social

🫀 Researchers from #HelmholtzMunich, Roche Diagnostics, & TUM have created an integrated single-cell atlas of human atherosclerotic plaques, mapping immune & vascular cells and providing tools for research. 👉 Read more: t1p.de/fszz9 @tum.de

Imagine a Future Where Diseases Are Detected Before They Even Emerge  At #HelmholtzMunich, we work to make individual risks visible at an early stage – before disease develops.  👉 Discover more: t1p.de/6uxj7 @helmholtz.de #EarlyDetection #MedicineOfTheFuture #HealthResearch

🚀Prof. Niki Kilbertus, #HelmholtzMunich & @tum.de, receives ERC Starting Grant for DYNAMICAUS. His project merges #MachineLearning, causal inference & modeling to improve “if-then” reasoning in climate, health & epidemics. 👉 t1p.de/7c231 @erc.europa.eu @helmholtzai.bsky.social #ERCStG

Measuring Lung-Deposited Dose: A Step Toward Improved Therapies 🫁 A new comment by researchers at #HelmholtzMunich shows why measuring the lung-deposited dose is key for safer, more effective therapies. 👉 t1p.de/c9svi

New #Grant Supports #Fr1da Study on Early T1D Screening Breakthrough T1D supports the Fr1da-Cohort-Study from #HelmholtzMunich with a grant to strengthen early-stage #Type1Diabetes screening & care for children and families. 👉 t1p.de/i2z3c @bvkj.bsky.social

Using AI and DNA Signals to Detect Living Microbes 🔬 #HelmholtzMunich & @helmholtzai.bsky.social show #AI can infer microbial viability from raw nanopore signals – distinguishing live vs. dead microbes for more precise genomic diagnostics in health & environmental monitoring. 👉 t1p.de/t692x

New Collaboration – Advancing Drug Discovery for Pulmonary Fibrosis 🫁 #HelmholtzMunich & Boehringer Ingelheim join forces to find new treatment options for #PulmonaryFibrosis using single-cell genomics & #AI. 👉 t1p.de/qhm8a @boehringerglobal.bsky.social @fabiantheis.bsky.social #AIinMedicine

📣Sign up for the Bavarian Conference on AI in Medicine at the #BAdW! #HelmholtzMunich co-organizes the conference uniting #AI experts & beginners to discuss advances in AI-driven medical research. 👉 Register & submit your abstract: t1p.de/8fuuw 🔽Read more in the comments.🔽

🎧#Podcast with Prof. Vasilis Ntziachristos about Photoacoustic Imaging: 👉https://t1p.de/o4n9t Learn more about groundbreaking medical imaging tools in the #HelmholtzMunich Highlight: "The Light that Listens to Health and Disease" 👉https://t1p.de/szrqp @munichimaging.bsky.social

Zooming in Reveals How Our Cells Work Inside Prof. Fabian Theis, #HelmholtzMunich, together with international partners, has helped to understand better how stem cells develop into blood cells. 👉 t1p.de/i34dh @fabiantheis.bsky.social #genomics #health #proteomics #bloodcells

CarePath: #HelmholtzMunich Joins EU Project The #CarePath initiative supports people with chronic conditions like #type2diabetes & #obesity through personalized tools to improve treatment adherence & wellbeing. #HelmholtzMunich is a central research partner in the five-year project: t1p.de/2ldqz

#HelmholtzMunich’s BNMRZ has joined Germany’s Instruct-ERIC Centre 🔬 Instruct-ERIC provides open access to advanced structural biology technologies. #BNMRZ advances innovation in #NMR methods, drug discovery, and imaging - boosting the German Centre’s capabilities. 👉 Read more: t1p.de/pjtyv

From Lab to Launch 🚀 #HelmholtzMunich joins Deep Science Ventures & SPRIND to support the Venture Science Doctorate – a new PhD program merging #science & #entrepreneurship. 👉 Read more: t1p.de/z4r0y 👉 Apply now: t1p.de/hpm7r @sprind-en.bsky.social @helmholtz.de #PhD2026 #VentureScienceDoctorate

🔬 New dual-imaging technology - #O2E - by #HelmholtzMunich, @tum.de ‬& @meduniwien.ac.at enables earlier detection of esophageal #cancer.‬‬‬ 👉 Read more in our news: t1p.de/qb9jh 🔗 To the original publication: t1p.de/ftgim @munichimaging.bsky.social

🔬 New study by #HelmholtzMunich, #DZD & Goethe University Frankfurt shows vidofludimus calcium may delay #Type1Diabetes by rebalancing immune cells. 👉 Read more: t1p.de/n6s0g @daniellab.bsky.social @diabresearch-dzd.bsky.social @goetheuni.bsky.social

Prof. Carsten Marr has assumed the W3 Professorship for AI in Cell Therapy & Hematology at LMU University Hospital. Marr also directs the Institute of AI for Health at #HelmholtzMunich. 🔬His #AI work advances diagnosis & treatment of blood diseases. 👉 Read more: t1p.de/enty6

Fighting #HepatitisB #TherVacB, a new therapeutic vaccine for chronic hepatitis B from #HelmholtzMunich, starts phase 1b/2a trial in patients. It aims to boost the immune system to eliminate the virus. 👉 t1p.de/qcncm @lmu-klinikum.bsky.social @tum.de @ulrike-protzer.bsky.social

🌱 When Roots Warn Shoots: Discovery Sheds Light on Plant-Wide Immunity Researchers at #HelmholtzMunich found that N-hydroxypipecolic acid (NHP) acts as a root-to-shoot signal, linking soil microbes to whole-plant defense – a key step for resilient, productive crops. 👉Read more: t1p.de/rguhm

🔬 New study: The #liver plays an active role in cancer #cachexia via silenced clock gene REV-ERBα. Key step toward new therapies. 👉 Read more: t1p.de/eh136 @tum.de @diabresearch-dzd.bsky.social @dorie00.bsky.social ky.social #CancerResearch #Cachexia #Liver

Good mood & fast legs at #B2Run2025 🏃‍♀️🏃‍♂️ Over 90 colleagues from #HelmholtzMunich ran through Olympiapark – under the motto "Research is a marathon, not a sprint”. Big thanks to all supporters & to Stiftung AtemWeg for the shirts! #CorporateHealth